Table 2. Clinical and metabolic characteristics of subjects according to plasma NOV levels.
| Men (Median = 4.81 ng/ml) | Women (Median = 5.20 ng/ml) | |||
| <Median (n = 121) | >Median (n = 121) | <Median (n = 176) | >Median (n = 176) | |
| Age (y) | 51.8±126 | 53.6±16.3 | 49.3±13.5 | 47.1±16.5 |
| BMI(kg/m2) | 29.2±7.2 | 33.7±8.8*** | 34.3±9.5 | 38.3±9.6*** |
| Fat Mass (%) | 24.0±8.9 | 28.6±8.4*** | 38.1±8.9 | 41.6±7.1*** |
| BG (mmol/l) | 5.80±1.40 | 6.17±2.19 | 5.41±1.51 | 5.45±1.51 |
| HbA1c (%) | 6.15±1.02 (5.8/5.6–6.4) | 6.43±1.32 (6.1/5.7–6.7) | 5.88±0.77(5.7/5.4–6.1) | 6.06±0.93 (5.8/5.5–6.3) |
| CRP (mg/l) | 2.01±3.21 (1.0/0.5–2.2) | 3.96±5.20**(2.2/1.2–4.0) | 3.87±6.65(1.3/0.6–4.0) | 3.91±4.42 (2.0 0.9–5.75) |
| TC (mg/dl) | 189.5±41.6 | 187.7±41.2 | 201.4±38.6 | 193.0±37.8 |
| HDL-C(mg/dl) | 43.4±13.2 | 40.6±11.0 | 53.0±15.5 | 54.3±16.6 |
| LDL-C(mg/dl) | 117.9±38.0 | 113.5±37.6 | 125.1±35.4 | 115.1±31.8 |
| TG (mg/dl) | 145.5±106.6(117/81–172) | 177.9±127.6*(148/93–228) | 116.6±64.0(90.5/61–145.5) | 120.9±101.7(104/69.8–139.3) |
| apoAI (mg/dl) | 132.2±26.2 | 131.8±20.7 | 148.6±28.4 | 144.6±30.8 |
| apoB (mg/dl) | 99.5±26.1 | 100.0±24.2 | 100.7±24.9 | 96.9±24.2 |
Data are expressed as the mean ± standard deviation. Values in parentheses indicate median/Q1–Q3. BMI, body mass index; BG, blood glucose; CRP, C-reactive protein; TC, total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglycerides; apo, apolipoprotein.
***
p<0.0001;
**
p<0.003 and *p<0.02.